Quantification of Pain Relief With Gonadal Vein Embolization for Pelvic Congestion Syndrome

What this Trial Is About

Chronic pelvic pain affects nearly 40% of women during their lifetime, with pelvic congestion syndrome (PCS) responsible for up to 30% of these cases. PCS is caused by problems in the gonadal veins, leading to painful swelling in the pelvic veins. While medical treatments aim to reduce ovarian function and tighten the veins, they often provide limited and short-term relief. This research aims to measure how much pain relief patients experience after undergoing coil embolization of the gonadal veins and to identify factors that predict better or worse outcomes. Participants will have coil embolization of the gonadal veins, a procedure performed to block the veins causing the congestion. This study observes patients treated in the Interventional Radiology division between October 2018 and October 2019. The degree of pain relief will be assessed over time, focusing especially on changes from before the procedure to one year after. Women in the study will be assessed using the Pelvic Congestion Symptom Pain Scale at baseline and up to 360 days after the embolization. Researchers will monitor pain levels and analyze clinical or imaging characteristics that might predict treatment response. The total participation time covers one year post-procedure, during which pain and treatment outcomes will be carefully tracked.

Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization